Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response.

Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences

NCT05801770 ·Status: NOT_YET_RECRUITING

A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer

NCT00001442 ·Status: COMPLETED ·Phase: PHASE1

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

NCT00049140 ·Status: COMPLETED ·Phase: PHASE2

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

NCT04747054 ·Status: RECRUITING ·Phase: PHASE3

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

NCT04319471 ·Status: UNKNOWN ·Phase: PHASE2

Quality of Life Before and After Radiotherapy in Patients With Head and Neck Cancer

NCT06807697 ·Status: COMPLETED

Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT

NCT04996147 ·Status: TERMINATED

Phase II Study Exploring Five Fractions of Post-operative Radiation Therapy in Head and Neck Cancer

NCT05648461 ·Status: NOT_YET_RECRUITING ·Phase: NA

Ovarian Function of Nasopharyngeal Carcinoma Women Survivors

NCT05183724 ·Status: NOT_YET_RECRUITING

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

NCT03040999 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Hypofractionated Dose Escalated VMAT to Conventional CCRT in Locally Advanced Head and Neck Cancer

NCT03699969 ·Status: UNKNOWN ·Phase: NA

Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

NCT06880289 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

ctDNA and MRI Parameters in Head and Neck Cancer

NCT06215612 ·Status: NOT_YET_RECRUITING ·Phase: NA

Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation Therapy

NCT03611205 ·Status: WITHDRAWN ·Phase: NA

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

NCT05544136 ·Status: RECRUITING ·Phase: PHASE2

Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma

NCT02943044 ·Status: UNKNOWN

Prognostic Immune Biomarkers in HNSCC

NCT05941676 ·Status: COMPLETED

Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT02277184 ·Status: TERMINATED ·Phase: PHASE1

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

NCT01466244 ·Status: COMPLETED

[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

NCT06794372 ·Status: RECRUITING ·Phase: PHASE2

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

NCT02031250 ·Status: COMPLETED ·Phase: PHASE2

MRI in Finding Hypoxia in Patients Undergoing Chemo and Radiation for Head and Neck Cancer

NCT00896350 ·Status: TERMINATED ·Phase: PHASE1

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

NCT03955367 ·Status: UNKNOWN ·Phase: PHASE3

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

NCT00002476 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma

NCT06530914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2